MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
3.850
+0.980 (34.15%)
At close: May 22, 2026, 4:00 PM EDT
3.620
-0.230 (-5.97%)
After-hours: May 22, 2026, 7:59 PM EDT
MetaVia Market Cap
MetaVia has a market cap or net worth of $19.88 million as of May 22, 2026. Its market cap has increased by 177.68% in one year.
Market Cap
19.88M
Enterprise Value
6.35M
1-Year Change
177.68%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $19.88M, a decrease of -99.98%. That is a compound annual growth rate of -73.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 19.88M | 7.27% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 15.91M |
| SeaStar Medical Holding | 15.83M |
| Vyome Holdings | 15.65M |
| Cocrystal Pharma | 15.58M |
| Lexaria Bioscience | 15.01M |
| Ernexa Therapeutics | 14.53M |
| CytoMed Therapeutics | 14.44M |
| Genenta Science | 13.92M |